Idea principal
Across 22 reports (7 randomized), acute exercise showed no clear effect on seroprotection after influenza vaccination, for example H1N1 RR 0.88 (95% CI 0.65-1.21; k = 3). Evidence certainty was low or very low and trials were few, so the data neither prove equivalence nor rule out a benefit.
Study design
Revisión de evidencia
Reading basis
Published abstract
Reading focus
Design & applicability
Esta explicación editorial está disponible en inglés, chino simplificado y chino tradicional. Esta interfaz muestra la lectura en inglés.
Pregunta de investigación
Exercise and fitness have been proposed as natural vaccine boosters, but small studies disagree. The authors tested whether assigned acute exercise or chronic training changes antibody responses to influenza vaccine in adults, and whether habitual activity and fitness are linked to them.
Población y método
Systematic review and meta-analysis. PubMed, Web of Science, Embase, Cochrane Library, Scopus and SPORTDiscus were searched from inception to May 1, 2026. Randomized evidence was analyzed separately for acute exercise and chronic training; nonrandomized interventions and observed activity or fitness were considered separately. Risk ratios (RRs) and mean differences (MDs) in log2 hemagglutination inhibition (HAI) titers were pooled when data allowed, with design-appropriate risk-of-bias tools and GRADE.
Resultados
The authors’ reported results. Read each estimate with its population and uncertainty.
- 122 reports were included; 7 randomized reports gave primary estimates, and 5 contributed to at least one meta-analysis of 2 or more trials.
- 2Acute exercise showed no clear effect on H1N1 seroprotection (RR 0.88, 95% CI 0.65-1.21; k = 3), H3N2 seroprotection (RR 1.04, 0.91-1.20; k = 3), H1N1 seroconversion (RR 1.30, 0.58-2.92; k = 2) or H3N2 seroconversion (RR 0.84, 0.50-1.40; k = 2).
- 3Chronic training titer estimates were imprecise: H1N1 MD 0.50 log2 units (-0.64 to 1.64; k = 2), H3N2 0.27 (-0.17 to 0.72; k = 2) and influenza B -0.14 (-0.64 to 0.36; k = 2). Other primary comparisons rested on single trials.
- 4Certainty of evidence was low or very low.
Límites e incertidumbre
- 1Each pooled analysis had only 2 or 3 trials, so the wide intervals fit both a benefit and no effect.
- 2Antibody levels are a surrogate: the abstract states these findings do not establish effects on clinical influenza.
- 3Observational associations of activity and fitness with vaccine response are open to confounding, and the available trials lacked complete numerical reporting.
- 4This reading is based on the abstract only.
Relevancia práctica
There is no solid evidence that a workout before or after a flu shot, or a training programme, raises antibody levels, but the data are too thin to say it does nothing. Stay with your usual routine and follow vaccination advice from your clinician.
Tus datos
Workout logs, training load and fitness estimates from a tracker could be recorded alongside your vaccination date, but no such pattern can be tested from personal data. Keep any comparison to your own routine and do not link it to vaccine protection.
Cómo interpretar la evidencia
Check which designs were included, how searches and bias assessment were conducted, and the last search date. Publication date alone does not make the underlying evidence current.
Resumen estructurado de los autores English
El resumen original en inglés se reproduce con atribución bajo la licencia indicada. Es una fuente, no una interpretación de MoveVitals. El análisis preparado figura arriba; verifica los resultados importantes en la fuente.
Background
Exercise, habitual physical activity, and physical fitness have been proposed as behavioral adjuvants that could improve influenza vaccine immunogenicity, but individual studies are small and inconsistent.
Objective
To evaluate the effects of assigned acute and chronic exercise interventions, and the associations of habitual activity and fitness, with humoral responses to influenza vaccination in adults.
Methods
We searched PubMed, Web of Science, Embase, Cochrane Library, Scopus, and SPORTDiscus from inception to May 1, 2026. Randomized evidence was analyzed separately for acute exercise and chronic training; nonrandomized interventions and observed activity or fitness were considered separately. Risk ratios (RRs) and mean differences (MDs) in log_(2) hemagglutination inhibition (HAI) titers were synthesized when compatible numerical data were available. Design-appropriate risk-of-bias tools and GRADE were applied.
Results
Twenty-two reports were included. Seven randomized reports provided primary quantitative estimates, and five contributed to at least one meta-analysis of two or more trials. Acute exercise did not show a clear effect on H1N1 seroprotection (RR 0.88, 95% CI 0.65-1.21; k = 3) or H3N2 seroprotection (RR 1.04, 0.91-1.20; k = 3), or on H1N1 seroconversion (RR 1.30, 0.58-2.92; k = 2) or H3N2 seroconversion (RR 0.84, 0.50-1.40; k = 2). Chronic-training titer estimates were imprecise for H1N1 (MD 0.50 log_(2) units, -0.64 to 1.64; k = 2), H3N2 (0.27, -0.17 to 0.72; k = 2), and influenza B (-0.14, -0.64 to 0.36; k = 2). Other primary comparisons were supported by single trials. Certainty was low or very low.
Conclusion
The available randomized evidence does not establish an immunogenicity benefit of acute exercise or chronic training, but does not demonstrate equivalence or exclude benefit. Observational associations remain vulnerable to confounding. Larger trials with complete numerical reporting are needed; these antibody findings do not establish effects on clinical influenza.
Systematic review registration
https://www.crd.york.ac.uk/PROSPERO/view/CRD420261425732, identifier CRD420261425732.
Fuentes y atribución
Exercise, physical activity, physical fitness, and humoral responses to influenza vaccination in adults: a systematic review and meta-analysis.
Hao X, Yu T, Liang W, Zong Y, Zhang Y, Hou Y, Sun Z.
Frontiers in immunology · 2026-10-08
DOI: 10.3389/fimmu.2026.1950491 ↗PubMed · 42923137 ↗Europe PMC · Licencia registrada: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interpretación editorial de MoveVitals · contenido educativo · sin revisión clínica individual registrada
Fuentes verificadas 2026-11-01
Guías prácticas
Leer en contexto
7,000 steps a day linked to lower risk of death, heart disease and dementia than 2,000
Compared with 2000 steps a day, 7000 steps was associated with a hazard ratio of 0.53 (95% CI 0.46 to 0.60) for all-cause mortality across 14 studies, 0.75 (0.67 to 0.85) for cardiovascular disease and 0.62 (0.53 to 0.73) for dementia; cancer incidence was not significantly different (0.94, 0.87 to 1.01). Several outcomes rest on only two to four studies, and the certainty of evidence ranged from moderate to very low.
The Lancet Public Health
Brief bursts of vigorous effort in daily life linked to lower mortality in non-exercisers
Among 25,241 UK Biobank adults who reported no leisure-time exercise, a median of 3 vigorous bouts of 1 or 2 minutes a day, picked up by a wrist accelerometer, was associated with a 38% to 40% lower risk of all-cause and cancer death and a 48% to 49% lower risk of cardiovascular death than no such bouts, over an average of 6.9 years and 852 deaths. This is an observational study using one week of wrist data and an algorithm to define vigorous effort, so it cannot show that adding such bursts causes the lower risk.
Nature Medicine
Steps and mortality: gains flatten near 6,000–8,000 (age 60+) and 8,000–10,000 (under 60)
Pooling 15 cohorts (47,471 adults, 3,013 deaths, median follow-up 7.1 years), the second, third and fourth quartiles of daily steps (medians 5,801, 7,842 and 10,901) had hazard ratios for death of 0.60, 0.55 and 0.47 against the lowest quartile (median 3,553). The curve flattened at about 6,000 to 8,000 steps a day for adults aged 60 and over and 8,000 to 10,000 for younger adults. The data are observational, from a single week of step counting, mostly with waist-worn research devices.
The Lancet Public Health
Accelerometers on 36,383 adults: any activity, even light, linked to lower mortality
In eight pooled cohorts (36,383 adults, mean age 62.6 years, 2,149 deaths over a median 5.8 years), the most active quarter by accelerometer-measured total activity had a mortality hazard ratio of 0.27 (95% CI 0.23 to 0.32) against the least active, and the most sedentary quarter had 2.63 (1.94 to 3.56). Light activity alone showed the same pattern, with 0.38 (0.28 to 0.51) in the top quarter. These are observational associations in adults aged 40 and over from the US and western Europe, so illness-driven inactivity and confounding cannot be excluded.
BMJ

